FDA Drug Application (021437) for INSPRA by GD SEARLE LLC

Back to FDA Applications sponsored by GD SEARLE LLC

Application Number021437
Product Number001
FormTABLET;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameINSPRA
Active IngredientEPLERENONE



Back to FDA Applications sponsored by GD SEARLE LLC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.